X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (152) 152
humans (134) 134
cervical cancer (115) 115
human papillomavirus (109) 109
female (107) 107
papillomavirus infections - prevention & control (84) 84
vaccines (69) 69
papillomavirus infections (61) 61
prophylactic vaccine (60) 60
virus-like particles (60) 60
immunology (59) 59
uterine cervical neoplasms - prevention & control (56) 56
vaccination (54) 54
papillomavirus vaccines - immunology (53) 53
cancer (52) 52
prophylactic vaccines (52) 52
particle vaccine (49) 49
adolescent (46) 46
hpv (45) 45
young-women (45) 45
adult (44) 44
papillomavirus vaccines - administration & dosage (44) 44
medicine, research & experimental (43) 43
animals (41) 41
prevention (39) 39
randomized controlled-trial (39) 39
infection (38) 38
prophylactic vaccination (34) 34
uterine cervical neoplasms - virology (34) 34
cervical intraepithelial neoplasia (31) 31
health aspects (31) 31
immunogenicity (31) 31
cervical-cancer (30) 30
immunization (30) 30
women (30) 30
young adult (29) 29
oncology (28) 28
vaccine (28) 28
papillomaviridae - immunology (27) 27
efficacy (26) 26
papillomavirus infections - immunology (26) 26
papillomavirus infections - virology (26) 26
papillomavirus vaccines - therapeutic use (25) 25
human-papillomavirus type-16 (23) 23
prophylactic (23) 23
antibodies, viral - blood (22) 22
papillomavirus infections - complications (22) 22
papillomaviruses (22) 22
follow-up (21) 21
research (21) 21
child (20) 20
clinical trials (20) 20
human papillomavirus 16 - immunology (20) 20
public health (20) 20
allergy and immunology (19) 19
analysis (19) 19
antibodies (19) 19
antigens (19) 19
capsid proteins - immunology (19) 19
intraepithelial neoplasia (19) 19
mice (19) 19
risk factors (19) 19
sustained efficacy (19) 19
obstetrics & gynecology (18) 18
papillomavirus infections - epidemiology (18) 18
therapeutic vaccine (18) 18
double-blind (17) 17
immune response (17) 17
male (17) 17
papillomavirus vaccines (17) 17
papillomavirus vaccines - adverse effects (17) 17
quadrivalent vaccine (17) 17
care and treatment (16) 16
genital warts (16) 16
hpv-16/18 as04-adjuvanted vaccine (16) 16
oncogene proteins, viral - immunology (16) 16
article (15) 15
human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18 (15) 15
infections (15) 15
prevalence (15) 15
proteins (15) 15
safety (15) 15
therapeutic vaccines (15) 15
biotechnology & applied microbiology (14) 14
cervical intraepithelial neoplasia - prevention & control (14) 14
human papillomavirus 18 - immunology (14) 14
type-16 (14) 14
uterine cervical neoplasms - immunology (14) 14
cancer vaccines (13) 13
cervical intraepithelial neoplasia - virology (13) 13
medical research (13) 13
prophylactic hpv vaccines (13) 13
united-states (13) 13
adjuvants, immunologic - administration & dosage (12) 12
clinical trials as topic (12) 12
cost-effectiveness (12) 12
diagnosis (12) 12
immune-responses (12) 12
infectious diseases (12) 12
medicine, general & internal (12) 12
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (203) 203
German (7) 7
Spanish (5) 5
French (3) 3
Portuguese (3) 3
Czech (2) 2
Korean (2) 2
Chinese (1) 1
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


VACCINE, ISSN 0264-410X, 08/2006, Volume 24, pp. 114 - 121
Early data from randomized controlled trials consistently show that prophylactic human papillomavirus virus-like particle (HPV VLP) vaccines are effective in... 
MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | HUMAN-PAPILLOMAVIRUS TYPE-16 | CLINICAL-TRIAL | EFFICACY | DYSPLASIA | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | prophylactic vaccines | cervical cancer | CERVICAL INTRAEPITHELIAL NEOPLASIA | HPV | PARTICLE VACCINE | VETERINARY SCIENCES | YOUNG-WOMEN | prevention
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 34, Issue 39, pp. 4724 - 4731
Journal Article
Vaccine, ISSN 0264-410X, 08/2018, Volume 36, Issue 32, pp. 4768 - 4773
HPV L1 virus-like particle (VLP) vaccines administered in a prime/boost series of three injections over six months have demonstrated remarkable prophylactic... 
Prophylactic vaccine | Human papillomavirus | Virus-like particle | HPV | MEDICINE, RESEARCH & EXPERIMENTAL | LONG-TERM IMMUNOGENICITY | OF-STUDY ANALYSIS | COSTA-RICA VACCINE | IMMUNOLOGY | HPV-16/18 AS04-ADJUVANTED VACCINE | CERVICAL INTRAEPITHELIAL NEOPLASIA | B-CELL ANERGY | HUMAN-PAPILLOMAVIRUS VACCINES | AGED 18-45 YEARS | VIRUS-LIKE PARTICLES | BLIND PATRICIA TRIAL | Virion - immunology | Mass Vaccination | Pre-Exposure Prophylaxis - methods | Papillomavirus Vaccines - therapeutic use | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - therapeutic use | Vaccines, Virus-Like Particle - therapeutic use | Humans | Clinical Trials as Topic | Papillomavirus Infections - therapy | Papillomaviridae - immunology | Vaccines, Virus-Like Particle - administration & dosage | Animals | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Antibodies, Viral - immunology | Female | Immunization Schedule | Mice | Program Evaluation | Papillomavirus Vaccines - administration & dosage | Antigens | Vaccines | Health aspects | Papillomavirus infections | Medical research | Immunization | Immunoglobulins | Virions | Clinical trials | Life cycle engineering | Viruses | Infections | Virus-like particles | Life cycles | Index Medicus
Journal Article
Intervirology, ISSN 0300-5526, 03/2018, Volume 60, Issue 4, pp. 125 - 130
Objective: Human papillomavirus (HPV) vaccination is currently not included in the national vaccination program in Iran. Regional data on the distribution of... 
Original Paper | Prevalence | Prophylactic vaccines | Human papillomavirus types | Cervical cancer | METAANALYSIS | GENOTYPE DISTRIBUTION | VACCINATION | CANCER | VIROLOGY | DNA | INFECTION | BURDEN | EPIDEMIOLOGY | SPAIN | Index Medicus
Journal Article
Recent Patents on CNS Drug Discovery, ISSN 1574-8898, 08/2016, Volume 10, Issue 2, pp. 284 - 289
The casual relationship concerning Human papillomaviruses (HPV) and cervical cancer is already established. Therefore, such HPV-associated malignancies might... 
Clinical phases of HPV vaccines | Prophylactic human papillomavirus vaccines (HPV) | HPV2 | Clinical development of HPV vaccines | HPV4
Journal Article
VACCINE, ISSN 0264-410X, 08/2006, Volume 24, pp. 147 - 153
Prophylactic human papillomavirus (HPV) vaccines based on intramuscular injection of non-infectious L1 virus-like particles (VLPs) are undergoing intense... 
MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN VACCINE | L1 PROTEIN | mucosal vaccines | DELIVERY-SYSTEMS | ESCHERICHIA-COLI | DNA vaccines | MUCOSAL | IMMUNOLOGY | prophylactic vaccines | viral vectors | therapeutic vaccines | RECOMBINANT | IMMUNE-RESPONSES | VIRUS-LIKE PARTICLES | VETERINARY SCIENCES | HEALTHY-VOLUNTEERS | PAPILLOMAVIRUS TYPES | bacterial vectors
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Women | Studies | Human papillomavirus | Immunization | Teenagers | Vaccines | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 05/2014, Volume 10, Issue 5, pp. 1155 - 1165
Journal Article